SB 772 requires the Maryland Department of Health to create and maintain a public database of employment training and job placement programs. The database will help residents find opportunities that can lead to eligibility for Medicaid (Maryland Medical Assistance Program) and SNAP (Supplemental Nutrition Assistance Program), including program details, application steps, and direct contact options. The Department must update the database every 30 days and assist individuals in enrolling in listed programs. Other state agencies, including the Department of Labor and Department of Human Services, must recommend programs for inclusion. This bill directly affects Maryland residents seeking to improve employment prospects while maintaining access to critical health and nutrition benefits.
This bill prohibits insurers, nonprofit health plans, and health maintenance organizations from denying emergency room coverage solely because a patient did not experience a diagnosed emergency medical condition. It requires two key studies: one to quantify hospital and post-acute care bed capacity across Maryland, and another to identify ways to improve transitions from emergency to post-acute care settings. These provisions directly affect patients receiving emergency care and healthcare providers treating them, ensuring coverage isn't denied based on diagnosis alone. The studies aim to inform data-driven recommendations for future policy improvements in emergency and post-acute care access.
HB 1012 authorizes counties and municipalities in Maryland to establish local suicide fatality review teams, which directly affect local governments and public health agencies. These teams must include representatives from health departments, law enforcement, schools, hospitals, and mental health professionals to review suicide cases and identify systemic factors. The bill requires teams to coordinate with the state suicide review committee and mandates confidentiality for case discussions, exempting meetings about individual cases from public disclosure laws and protecting sensitive information. It also prohibits public disclosure of identifying details about deceased individuals or those affected by suicide, ensuring privacy while allowing teams to develop prevention recommendations.
SB 719 restricts the land application of sewage sludge containing per- and polyfluoroalkyl substances (PFAS) above specific concentration levels, effective after a set date. It requires monitoring for PFAS in sewage sludge and products containing it, authorizes stricter pretreatment rules for industrial users discharging PFAS, and allows local jurisdictions to set fees for such discharges. The bill directly affects sewage sludge generators (like wastewater treatment facilities), industrial users, and local regulators by mandating new PFAS testing, usage limits, and fee structures. It amends Maryland’s environmental code to establish these requirements without changing existing land application rules for sludge below the new PFAS thresholds.
HB 771 requires Maryland health occupations boards to allow license renewal credits for free, 1-hour human trafficking awareness training. The training must cover definitions of trafficking, trauma-informed care, health indicators, screening protocols, reporting requirements, and survivor resources. It directly affects health practitioners (like nurses and therapists) needing license renewals, with boards mandated to adopt regulations by October 2026. The Maryland Department of Health must approve the training program by July 2026 in collaboration with universities and anti-trafficking organizations. The bill takes effect June 1, 2026.
HB 1533 (the Crown and Care Act) bans 12 specific harmful ingredients - including certain phthalates, formaldehyde, mercury, and PFAS chemicals - from cosmetic products sold in Maryland. It directly affects cosmetic manufacturers, retailers, and salons by prohibiting the sale or distribution of products containing these ingredients, with limited exceptions for unavoidable trace amounts from manufacturing processes. The bill authorizes the Maryland Department of Health to investigate complaints, inspect businesses, and enforce penalties, while allowing consumers harmed by violations to seek civil damages and attorney fees. This law aims to protect public health by reducing exposure to chemicals linked to health risks like skin irritation and potential long-term harm.
HB 1483 repeals Maryland's requirement for out-of-state clinical counselors to obtain a temporary telehealth license. It allows licensed counselors from other states to provide telehealth counseling to clients who relocated to Maryland (or returned after relocating), for up to six months, if they already had an established client-counselor relationship before the move. This exempts these counselors from Maryland's standard licensure rules during the six-month continuity period, but only for existing clients who relocated - not for new clients. The bill does not change regular licensing requirements for ongoing practice in Maryland.
SB 773 allows pharmacists in Maryland to order certain vaccinations (like flu, COVID-19, or emergency vaccines) for patients aged 3 and older without needing to administer the vaccine themselves. To qualify, pharmacists must complete 20 hours of approved training, hold current CPR certification, and complete 2 hours of continuing education on immunizations. The bill requires pharmacists to follow written vaccine-specific protocols, report all vaccinations to Maryland’s ImmuNet registry, and refer pediatric patients to primary care providers when appropriate. This policy directly affects pharmacists, patients seeking these vaccines, and healthcare coordination for immunizations. The changes take effect October 1, 2026.
SB 778 creates a new "clinical research pharmacy permit" required for pharmacies conducting clinical trials in Maryland. It allows healthcare providers to own such pharmacies under specific conditions, including requiring a licensed pharmacist to be on-site at all times and prohibiting owners from receiving payment for patient referrals. The bill also exempts clinical trials conducted by corporations from being classified as "practice of medicine," removing a licensing barrier for these activities. This directly affects pharmacies seeking to operate clinical trials, healthcare providers considering ownership, and the State Board of Pharmacy (as the permit issuer).
SB 159 requires Maryland's Emergency Medical Services (EMS) providers to maintain specific equipment and supplies on ambulances, including neonatal care items, and mandates quarterly reviews of performance data like response times and service quality. It also requires counties to establish formal, accessible complaint systems for ambulance quality or conduct issues, with online and in-person filing, tracking, and quarterly reporting to the state EMS Institute. These provisions directly affect all counties and municipalities operating or contracting EMS services, as well as the Maryland Institute for EMS Systems, which coordinates the statewide standards. The bill aims to standardize ambulance equipment, improve accountability through data reviews, and enhance patient access to complaint resolution. It takes effect July 1, 2026.
